Takeda’s Qdenga Vaccine: A Breakthrough in Dengue Prevention Coming to India
Colorectal cancer is one of the most prevalent cancers across the world. It is characterized by abnormal cell growth in ...
Indian Company Can Manufacture Risdiplam for Spinal Muscular Atrophy (SMA)
In a major development, a leading Indian pharmaceutical company, Natco Pharma, has been given approval to produce Risdiplam. This is ...
FDA Approves Qfitlia (Fitusiran) for Hemophilia A or B, with or without Factor Inhibitors
Introduction: The Promise of Qfitlia for Hemophilia Treatment The FDA has authorized Qfitlia (Fitusiran), a new treatment for both Hemophilia ...
FDA Approves First Treatment for a Rare Lipid Storage Disease
On February 21, 2025, the Food and Drug Administration of the United States (FDA) approved Ctexli (chenodiol) for CTX therapy ...
FDA Approves Tenecteplase for Acute Ischemic Stroke (AIS)
Recently, the U.S. Food and Drug Administration (FDA) approved TNKase (tenecteplase) for the use of treating adults with acute ischemic ...
First Generic GLP-1 Injection to Treat Type 2 Diabetes is Approved by FDA
On December 23, 2024, the FDA approved the first generic Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) ...
WHO Approves World’s First Diagnostic Test for MPox
The World Health Organization (WHO) has taken a critical step in improving global access to MPox testing by listing the ...
FDA Approves Miplyffa: First-Ever Drug for Niemann-Pick Disease, Type C (NPC)
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved Miplyffa (arimoclomol), a groundbreaking treatment for Niemann-Pick disease, ...
MPOX Virus Truths: Is It a Real Public Health Threat or a Hoax?
The World Health Organization (WHO) has labeled the multi-country outbreak of Mpox a public health emergency, raising concerns worldwide. Given ...